title: Outcome of patients with electrocardiographic evidence of left ventricular hypertrophy following thrombolytic therapy for acute myocardial infarction.
authors.affiliation: The Heart Institute, Sheba Medical Center, Tel Hashomer, Israel.
authors.forename: I
authors.initials: I
authors.lastname: Goldenberg
authors.forename: S
authors.initials: S
authors.lastname: Matetzky
authors.forename: H
authors.initials: H
authors.lastname: Hod
authors.forename: S
authors.initials: S
authors.lastname: Behar
authors.forename: D
authors.initials: D
authors.lastname: Freimark
mesh_terms: D000368:Aged; D004311:Double-Blind Method; D004562:Electrocardiography; D005260:Female; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000175:diagnosis* / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000150:complications* / Q000628:therapy*; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D013300:Streptokinase / Q000627:therapeutic use; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
chemical_list: D013300:Streptokinase; D010959:Tissue Plasminogen Activator